TetraLogic Pharmaceuticals OverviewTetraLogic Pharmaceuticals Research & Development
Research & Development expenses for TLOG.
Quarterly R&D Expenses
$38256.00
↓ 99.37% YoY
As of Sep 30, 2016
Annual R&D Expenses (TTM)
$11.99M
↓ 54.91% YoY
Trailing 12 months ending Sep 30, 2016